Plasma cell neoplasms result from the monoclonal proliferation of plasma cells. They include plasma cell myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, and primary amyloidosis. Plasma cell myeloma is characterized by bone marrow-based monoclonal plasma cell proliferation, a serum M-component, and osteolytic bone lesions. Diagnosis involves clinical features like bone pain, radiological features like lytic bone lesions, and laboratory tests showing monoclonal bands, anemia, and hypercalcemia.
Plasma cell neoplasms result from the monoclonal proliferation of plasma cells. They include plasma cell myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, and primary amyloidosis. Plasma cell myeloma is characterized by bone marrow-based monoclonal plasma cell proliferation, a serum M-component, and osteolytic bone lesions. Diagnosis involves clinical features like bone pain, radiological features like lytic bone lesions, and laboratory tests showing monoclonal bands, anemia, and hypercalcemia.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
Plasma cell neoplasms result from the monoclonal proliferation of plasma cells. They include plasma cell myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, and primary amyloidosis. Plasma cell myeloma is characterized by bone marrow-based monoclonal plasma cell proliferation, a serum M-component, and osteolytic bone lesions. Diagnosis involves clinical features like bone pain, radiological features like lytic bone lesions, and laboratory tests showing monoclonal bands, anemia, and hypercalcemia.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
AGENDA Definition Classification Plasma Cell Neoplasms Definition - Immuno-secretory disorders resulting from expansion of a single clone (monoclonal) of immunoglobulin secreting terminally differentiated, end-stage B cells (plasma cells). - Secretion of a monoclonal homogenous immunoglobulin product (M-component). Plasma Cell Neoplasms Pro-T Lymphocyte Pre-T Lymphocyte
Cytotoxic T Lymphocyte
Helper T Lymphocyte
Lymphoid Stem Cell
Pre-B Lymphocyte B Lymphocyte Plasma Cell
Plasma Cell Neoplasms Classification • Plasma Cell Myeloma • Monoclonal Gammopathy of Undetermined Significance (MGUS) • Plasmacytoma • Primary Amyloidosis Plasma Cell Neoplasms • Plasma Cell Myeloma - Definition - Epidemiology - Diagnosis Plasma Cell Neoplasms • Plasma Cell Myeloma Definition - Bone marrow-based multifocal monoclonal plasma cell proliferation characterized by serum M- component and osteolytic lesions. - Spectrum of severity (indolent- to-aggressive) Plasma Cell Neoplasms • Plasma Cell Myeloma Epidemiology - ~ 15% of hematological malignancies. - Disease of elderly (6th – 7th decade). Plasma Cell Neoplasms • Plasma Cell Myeloma Diagnosis A) Clinical Features B) Radiological Features C) Laboratory Features Plasma Cell Neoplasms • Plasma Cell Myeloma Diagnosis (cont’d) A) Clinical Features - Extensive skeletal destruction: bone pain, pathological fractures - Excessive monoclonal immunoglobulin production: hyperviscosity syndrome - Depressed normal immunoglobulin production: recurrent infections - Bone marrow replacement: anemia, thrombocytopenia (late) Plasma Cell Neoplasms • Plasma Cell Myeloma Diagnosis (cont’d) B) Radiological Features - Lytic bone lesions Plasma Cell Neoplasms Plasma Cell Neoplasms Plasma Cell Neoplasms Plasma Cell Neoplasms • Plasma Cell Myeloma Diagnosis (cont’d) C) Laboratory Features - Hematology CBC, PBS examination, BM examination - Serum Protein Electrophoresis (SPE) Monoclonal band (IgG, IgA), hypogammaglobulinemia - Urine Protein Electrophoresis Bence-Jones Protein - Others hypercalcemia, renal impairment PBS BM BM Plasma Cell Neoplasms
Polyclonal vs. Monoclonal Ig Production
Plasma Cell Neoplasms • Plasma Cell Myeloma Diagnostic Criteria Major Criteria Minor Criteria
Marrow plasmacytosis (30%) Marrow plasmacytosis
(10-30%) Plasmacytoma on biopsy M-component M-component (serum or urine) Lytic bone lesions Serum IgG > 35g/L, IgA > 20g/L Hypogammaglobulinemia Urine > 1g/24hrs of BJ protein Plasma Cell Neoplasms • MGUS - The presence of M-component in persons without evidence of plasma cell neoplasm. - ~ 25% will develop plasma cell neoplasm (~ 10years). - Follow up is essential. Plasma Cell Neoplasms • MGUS (cont’d) Diagnostic Criteria - M-component - Marrow plasmacytosis (< 10%) - No lytic bone lesions - No myeloma-related symptoms Plasma Cell Neoplasms • Plasmacytoma - Clonal proliferations of plasma cells that are identical to plasma cell myeloma but manifest a localized osseous or extraosseous growth pattern. Plasma Cell Neoplasms • Primary Amyloidosis - Plasma cell neoplasm that secretes an abnormal immunoglobulin, which deposits in various tissues and forms fibrillary protein (Amyloid). - Systemic deposition involving heart, liver, kidneys, GIT, tongue, nerves. - Binds Congo red stain to produce characteristic birefringence. - M-component in 80% of patients. - 20% have plasma cell myeloma. Congo red